Our in vivo data substantiate that through this mechanism, Id1-expressing ESCC tumours can indirectly promote the functional incorporation of VEGFR1+ bone marrow cells into primary tumours and secondary sites to facilitate tumour growth and formation of pre-metastatic niche. This evidence concerns the gene FLT1 and neoplasm.